New algorithm for early Lyme disease diagnosis
Comparative cost and effectiveness of a new algorithm for early Lyme disease diagnosis: evaluation in US, Germany, and Italy
Stay updated with breaking news from Sensitivity Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Comparative cost and effectiveness of a new algorithm for early Lyme disease diagnosis: evaluation in US, Germany, and Italy
Symposium on recent trends in engineering research
SilverCrest Announces Positive Feasibility Study Results and Technical Report Filing for the Las Chispas Project News provided by Share this article TSX: SIL | NYSE American: SILV VANCOUVER, BC, Feb. 2, 2021 /PRNewswire/ - SilverCrest Metals Inc. ("SilverCrest" or the "Company") is pleased to announce positive results from a Feasibility Study (the "Feasibility Study") for the Las Chispas Project ("Las Chispas" or the "Project") in Sonora, Mexico. Details of the Feasibility Study, including an updated Mineral Resource Estimate and an initial Mineral Reserve Estimate, are provided in a techn...
E-Mail IMAGE: Physicists have developed a new method that enables emulation of complex calculations at lightning speed. This could yield new insights about the quantum properties of strongly interacting matter such as... view more Credit: Illustration: Andreas Ekström and Yen Strandqvist/Chalmers University of Technology A calculation so complex that it takes twenty years to complete on a powerful desktop computer can now be done in one hour on a regular laptop. Physicist Andreas Ekström at Chalmers University of Technology, together with international research colleagues, has des...
Share this article Share this article ResearchAndMarkets.com's offering. The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period, 2020-2025. MRD Testing industry to be one of the most rapidly evolving and dynamic markets. The market is driven by certain factors, such as the rising incidence of hematologic malignancies, the increasing consumer awareness for tailored therapy, the increasing research funding from the National Cancer Institute, and the increasing disposable income in emerging economies. The market is favored by the developments in the...